0000904454-23-000604.txt : 20231113 0000904454-23-000604.hdr.sgml : 20231113 20231113095744 ACCESSION NUMBER: 0000904454-23-000604 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 EFFECTIVENESS DATE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Finepoint Capital LP CENTRAL INDEX KEY: 0001608126 IRS NUMBER: 462183973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16580 FILM NUMBER: 231395999 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 336-2200 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001608126 XXXXXXXX 09-30-2023 09-30-2023 false Finepoint Capital LP

500 Boylston Street 24th Floor Boston MA 02116

13F HOLDINGS REPORT 028-16580 000170668 801-79330 N Stacy L. Vezina 617-336-2212 Stacy L. Vezina Boston MA 11-13-2023 0 30 200795271 INFORMATION TABLE 2 infotable.xml ACADIA PHARMACEUTICALS INC COM 004225108 11598565 556553 SH SOLE 556553 0 0 AMICUS THERAPEUTICS INC COM 03152W109 18106544 1489025 SH SOLE 1489025 0 0 ARES ACQUISITION CORP *W EXP 02/02/202 G33032122 333611 504706 SH SOLE 504706 0 0 ARVINAS INC COM 04335A105 9912308 504700 SH SOLE 504700 0 0 ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 15335610 163772 SH SOLE 163772 0 0 BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121 304300 895000 SH SOLE 895000 0 0 CEREVEL THERAPEUTICS HLDNG I COM 15678U128 12297821 563345 SH SOLE 563345 0 0 CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115 0 612000 SH SOLE 612000 0 0 CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119 86400 540000 SH SOLE 540000 0 0 CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110 168784 548000 SH SOLE 548000 0 0 COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123 101271 459906 SH SOLE 459906 0 0 CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116 42589 408333 SH SOLE 408333 0 0 CYTOKINETICS INC COM NEW 23282W605 12717676 431693 SH SOLE 431693 0 0 CALIDI BIOTHERAPEUTICS INC COM NEW 320703101 415625 125000 SH SOLE 125000 0 0 CALIDI BIOTHERAPEUTICS INC *W EXP 03/14/202 320703119 144144 655200 SH SOLE 655200 0 0 GALAPAGOS NV SPON ADR 36315X101 15846668 458659 SH SOLE 458659 0 0 HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111 0 690000 SH SOLE 690000 0 0 MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113 13524 735000 SH SOLE 735000 0 0 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104 18890712 331416 SH SOLE 331416 0 0 MORPHIC HOLDING INC COM 61775R105 7453906 325356 SH SOLE 325356 0 0 PROTHENA CORP PLC SHS G72800108 16853725 349300 SH SOLE 349300 0 0 RELAY THERAPEUTICS INC COM 75943R102 7324017 870870 SH SOLE 870870 0 0 REVOLUTION MEDICINES INC COM 76155X100 11819360 427000 SH SOLE 427000 0 0 ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114 49023 439666 SH SOLE 439666 0 0 SAREPTA THERAPEUTICS INC COM 803607100 17620176 145357 SH SOLE 145357 0 0 SOLID BIOSCIENCES INC COM NEW 83422E204 2422353 961251 SH SOLE 961251 0 0 SPRINGWORKS THERAPEUTICS INC COM 85205L107 12876175 556928 SH SOLE 556928 0 0 SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111 34594 490000 SH SOLE 490000 0 0 TRAVERE THERAPEUTICS INC COM 89422G107 8008640 895821 SH SOLE 895821 0 0 YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117 17150 489999 SH SOLE 489999 0 0